Scopus
Hospitality · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1900 Powell St Ste 900, Emeryville, Cali...Phone Number
(510) 428-0500Website
www.scopus.comRevenue
<$5 MillionIndustry
About Scopus
Scopus Org Chart
Is Scopus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Scopus recently announced quarterly report
Scopus, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Scopus has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Scopus has new funding data
Check out if Scopus is spiking on competitors!
Product Launch: Get notified when Scopus launches new products
Click to see if Scopus had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Scopus
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Scopus
Compare insights from companies similar to Scopus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Scopus is experiencing very low activity levels compared to other companies in the Hospitality sector.
What does this means?
Scopus is drawing exceptional interest within the Hospitality industry, suggesting notable developments or strong market momentum, learn more about Scopus.
Scopus Tech Stack
A closer look at the technologies used by Scopus
Most Recent Scoops
Scopus News & Media
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, and its pure-play immuno-oncology subsidiary, Duet BioTherapeutics, today announced that key scientific data will be will be presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer (“SITC”).Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value
Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharma’s Pure Play Immuno-Oncology Subsidiary, Duet BioTherapeutics, Independently Valued at $25 Million Scopus Maintains Approximately 90% Ownership Stake in Duet Duet Being Positioned to Go Public in 2023 NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, aScopus BioPharma Announces Appointment of Additional Directors
NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment...Newly Listed Scopus Biopharma Soars Over 500%: What Investors Need to Know
Scopus Biopharma Inc (NASDAQ: SCPS) shares, which debuted on the Nasdaq Wednesday, are ripping higher. read more
Top Hospitality Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Scopus
Scopus is the largest abstract and citation databases of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research.... Read More